LRI Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Sell
2,982
-6
-0.2% -$6.13K 0.29% 47
2026
Q1
$2.75M Buy
2,988
+948
+46% +$961K 0.24% 51
2025
Q4
$2.19M Sell
2,040
-554
-21% -$530K 0.18% 63
2025
Q3
$1.98M Buy
2,594
+630
+32% +$469K 0.16% 63
2025
Q2
$1.53M Sell
1,964
-165
-8% -$128K 0.13% 69
2025
Q1
$1.76M Sell
2,129
-958
-31% -$797K 0.17% 59
2024
Q4
$2.38M Sell
3,087
-219
-7% -$181K 0.23% 39
2024
Q3
$2.6M Buy
3,306
+1,056
+47% +$949K 0.25% 36
2024
Q2
$2.04M Buy
2,250
+2,146
+2,063% +$1.72M 0.23% 36
2024
Q1
$80.9K Buy
+104
New +$74K 0.02% 224

Other funds holding LLY

LRI Investments's LLY Position: Q2 2026 in Review

LRI Investments reduced its Eli Lilly (LLY) stake by 0.2% in Q2 2026, selling an estimated $6.13K and leaving 2,982 shares worth $3.58M. The position accounts for 0.29% of the portfolio, ranked #47.

LRI Investments first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LRI Investments held 2,982 shares of Eli Lilly worth $3.58M as of Q2 2026.
  • LRI Investments sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.29% of LRI Investments's portfolio in Q2 2026, its #47 holding.
  • LRI Investments first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.